IBN SINA Pharma approved 38.50pc cash dividend: The IBN SINA Pharmaceutical Industry Limited, approved 38.50 percent cash dividend after evaluating the financial report of the tenure 1st July, 2019 to 30 June, 2020. The declaration came out from its 36th Annual General Meeting held on Thursday through virtually while Shah Abdul Hannan, chairman of the company presided over the meeting, said a press release. Prof. ANM A Zaher and Prof. Dr. Choudhury Mahmood Hasan were re-elected from Sponsor Directors. Prof. Dr. AKM Sadrul Islam, Managing Director, Md. Shahid Farooqui, Company Secretary and Executive Director, a lot of shareholders, were also present. The Directors’ report, Auditors’ report and Audited Financial statements were presented in the AGM for the tenure 1st July, 2019 to 30 June, 2020.